Haleon Pakistan Limited (PSX:HALEON)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
816.39
+16.64 (2.08%)
At close: Aug 1, 2025

Haleon Pakistan Company Description

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, rest of Asia, Africa, Australia, North America, the Middle East, and Europe.

The company offers oral health, pain relief, wellness and nutrition, and respiratory health products, as well as over-the-counter pharmaceutical products.

It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands.

The company also exports its products to Vietnam, the Philippines, and East West Africa region. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023.

Haleon Pakistan Limited was incorporated in 2015 and is headquartered in Karachi, Pakistan. Haleon Pakistan Limited is a subsidiary of Glaxosmithkline Consumer Healthcare B.V.

Haleon Pakistan Limited
CountryPakistan
Founded2015
IndustryPharmaceutical Preparations
Employees450
CEOQawi Naseer

Contact Details

Address:
11-A, Sky Tower (East Wing)
Karachi, 75600
Pakistan
Phone92 21 111 425 366
Websitehaleon.pk

Stock Details

Ticker SymbolHALEON
ExchangePakistan Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyPKR
SIC Code2834

Key Executives

NamePosition
Qawi NaseerChief Executive Officer
Dilawar MeghaniChief Financial Officer